RNS Number : 2706W
Xenetic Biosciences PLC
27 January 2012
 January 2012
Xenetic Biosciences plc
('Xenetic' or 'the Company')
Share movement by Serum Institute of India Concert Party
Xenetic Biosciences plc (LSE: XEN.L), a bio-pharmaceutical company specialising in the development of high-value differentiated biological and vaccines and novel cancer drugs, announces that it was today informed by Serum Institute of India Limited that it has sold, 13 million Xenetic shares to a concert party company.
Buyer details are as follows:
Name Chanda Investment & Trading Co Pvt Ltd
Trade Price 8.55 pence
No of shares 13,000,000
As a result of this transaction, the reported shareholding of Serum Institute of India and its related parties is unchanged, being, a total of 44,316,415 ordinary shares in the Company representing 11.67% of the Total Voting Rights.
- Ends -
This information is provided by RNS
The company news service from the London Stock Exchange